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Abstract: Continuously updated ST-segment recovery analysis has been 
shown to accurately predict infarct-related artery patency. Salient principles 
were converted into algorithms and incorporated into a portable ST monitor 
for optimal application. This study tested the automated program's ability to 
detect occlusion and reperfusion during balloon angioplasty. ST-segment 
recordings during 78 balloon occlusions in 31 patients were analyzed. The 
program requires at least one electrocardiogram with ST elevation of 200 lnV 
or greater in the recording, caused by the current occlusion or by a previous 
occlusion, before it will yield a patency prediction. All 35 inflations causing 
peak ST elevation of 200 pV or more were indeed detected. All five inflations 
causing less than 200 pV ST elevation preceded by an inflation causing 200 
pV or higher ST elevation were also detected. Occlusion was detected a
median of 40 seconds after inflation, and reperfusion a median of 17 seconds 
after deflation. Peak ST elevation greater than 200 pV occurred in 19 of 26 
left anterior descending artery inflations (73%), 1 of 22 left circumflex artery 
LCX inflations (5%), and 15 of 30 right coronary artery inflations (50%). Five 
different leads identified peak ST elevation through 12-lead surveillance. In 
this model of coronary occlusion during angioplasty balloon inflation, the 
automated patency assessment program appears to detect coronary angio- 
plasty balloon occlusion and reperfusion within seconds in all occlusions 
causing a peak ST elevation of 200 IJV or greater. Testing this automated 
patency assessment program as a noninvasive triage tool in myocardial infarc- 
tion patients eems warranted. Key words: automated ST-segment analysis, 
balloon angioplasty, coronary occlusion, reperfusion, patency assessment, 
acute myocardial infarction. 
Patients suffering acute myocardial infarction in 
whom thrombolytic therapy fails to provide early 
and stable reperfusion might benefit from addi- 
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tional pharmacologic or mechanical revasculariza- 
tion therapy (1-9). To study these patients with- 
out subjecting all patients to catheterization requires 
a practical, accurate, noninvasive method that is 
able to detect both reperfusion and reocclusion in 
real time. 
Analysis of ST-segment recovery has been 
shown to accurately predict infarct artery patency 
in a real-time emulation using dynamically updated 
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reference measurements during continuous digital 
12-lead ST-segment monitoring (10-12). The use 
of updated reference lectrocardiograms (ECGs) for 
comparison of ST measurements rather than static 
pre- and post-thrombolysis ECGs may result in 
more adequate prediction of patency when multi- 
ple ST recovery and reelevation episodes occur in 
the early phase of acute myocardial infarction 
(10-12). However, this continuous ST monitoring 
method of patency assessment requires transfer of 
the ECG data to a separate personal computer 
review station with software providing a three- 
dimensional graphic display of ST deviation over 
time in all 12 leads, as well as superimposed com- 
parison of single ECGs in full disclosure with mea- 
surements of ST deviation in each of the leads (ST- 
3D, Tampa Cardiovascular Associates, Tampa, FL) 
(10). The procedures for performing a patency 
assessment with this custom software include man- 
ual identification of peaks and troughs in the ST 
trendline over time, requiring both time and spe- 
cific training of the clinician. To enhance bedside 
application, the ST-segment recovery analysis 
should be a component of the free-standing moni- 
tor itself and should be accessible to less intensively 
trained physicians. Salient principles of the analysis 
method were therefore converted into algorithms 
and incorporated into the portable monitor as an 
automated patency assessment program (13). This 
study was designed as a first phase of testing the 
ability of this automated patency assessment sys- 
tem to detect known periods of coronary occlusion 
and reperfusion and the speed thereof, using 
angioplasty as a controlled human model. 
Materials and Methods 
Patient Population 
Patients undergoing elective percutaneous trans- 
luminal coronary angioplasty of one or more 
subtotal (75-99%) stenotic lesions were selected 
prospectively so that equal numbers of patients 
were included in three groups representing each of 
the three major coronary arteries. Patients were 
excluded if they had a history of coronary artery 
bypass operation or an acute myocardial infarction 
within 3 days before the angioplasty procedure. 
Patients who had a chronic total occlusion as a tar- 
get lesion, those with an intraventricular conduc- 
tion delay, and those undergoing an intervention 
with a device other than a conventional balloon 
were also excluded. Coronary angioplasty and ST- 
segment monitoring were performed according to 
standard practice in our institution. 
ST-Segment Monitoring 
The 12-lead ST monitor (ST100, Mortara Instru- 
ment, Milwaukee, WI) has been described in detail 
previously (14-16). In summary, the ST monitor 
acquires and digitizes a standard 12-lead ECG 
every 20 seconds, recognizing QRS onset in all 12 
leads simultaneously and creating a median beat 
complex out of each acquisition. The ST-segment 
measurements were performed by the ST monitor 
60 ms after the J point. For the purpose of this 
study, all acquired ECGs were stored in the moni- 
tor's memory. Torso lead placement (15) with 
radiotranslucent electrodes and impedance-regu- 
lated skin preparation (Quik Prep, Quinton Med- 
ical, Seattle, WA) were used to reduce noise. 
Automated Patency Assessment 
Details of the automated patency assessment 
method have been described previously (13). 
Briefly, continuously updated surveillance of all 12 
leads is used to select he most active lead, defined 
as the single lead showing the highest ST-segment 
elevation up to that moment. Amplitude measure- 
ments in this most active lead are then used to 
identify two ECGs, the last transition ECG and the 
maximum ECG, for comparison with the assess- 
ment ECG. As shown in Figure 1, the last transi- 
tion ECG is defined as the last ECG prior to the 
assessment ECG at which the trend of ST-segment 
amplitude over time changes from worsening 
(upsloping trend) to improvement (downsloping 
trend) or vice versa. Thus, the last transition ECG 
represents he last turning point in the trendline of 
ST amplitudes over time (13). The maximum ECG 
is defined as the ECG displaying the greatest ST- 
segment elevation in the most active lead during 
the recording episode up to the moment of assess- 
ment. With each new assessment ECG, the most 
active lead and the ECGs representing the maxi- 
mum ECG and the last transition ECG are auto- 
matically redefined. 
Analog waveforms from all three ECGs (assess- 
ment, maximum, last transition) are printed in 
hard copy as a comparison plot for inspection by 
the clinician. By pushing a button, the clinician 
may reject any ECG that contains unacceptable 
noise or conduction disturbance, after which the 
program selects a new ECG. After visual confirma- 
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Fig. I. ST-segment deviation over time measured in the 
peak lead (III) during three consecutive balloon infla- 
tions. The definition of the maximum ECG (M), last 
transition ECG (LT), and assessment ECG (A) are repre- 
sented above the trendline. Two arrows on the right side 
represent the two measurements that are used in a logic 
flow to come to an interpretative statement regarding 
patency of the coronary artery: the recovery in ST eleva- 
tion in the assessment ECG as a percentage of the maxi- 
mum ST elevation (% rec); and the 2-minute peak slope 
in the trendline between the last transition ECG and the 
assessment ECG. 
tion of satisfactory noise levels, two parameters of 
ST recovery are automatically calculated: (1) the 
ST amplitude recovery in the assessment ECG as a 
percentage of the max imum ECG ST amplitude; 
and (2) the peak 2-minute ST trend slope between 
the last transition ECG and the assessment ECG 
(Fig. 1). A window between two points 2 minutes 
apart is used "floating" backward from the assess- 
ment  ECG to determine the slope between these 
two points at each 20-second interval: worsening 
(upsloping -> 50 lay in 2 minutes), improvement  
(downsloping -< -50  pV in 2 minutes), or fiat. The 
last transition ECG is the last ECG prior to the 
assessment ECG at which the trend of ST ampli- 
tudes over time in the worst lead changes from 
upsloping to downsloping or vice versa (Fig. l). 
As previously described (13), the results of these 
two calculations are then conveyed through a sim- 
ple logic flow (Fig. 2) to produce a final interpreta- 
tive statement about coronary patency as occluded, 
indeterminate, or patent. If less than 50% recovery 
has occurred and the peak 2-minute ST slope is fiat 
or upsloping, the infarct-related artery is consid- 
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Fig. 2. Representation f the logic flow implemented in
the automated patency assessment program. The two 
measurements demonstrated in Figure 1 are used to 
COlZle to a final statement regarding infarct-related 
artery patency. Modified from Veldkamp et al. (13). 
With permission. 
ered to have remained occluded. A recovery of 
50% or more from the peak ECG, as well as a 
downsloping peak 2-minute ST slope, is required 
to assess the infarct-related artery as patent in 
order to differentiate it from gradual amplitude 
diminution due to loss of myocardial mass produc- 
ing injury current. If a recovery of less than 50% 
has occurred but the peak ST slope is downsloping, 
it is believed, but without enough certainty, that 
this might indicate the advent of reperfusion, and 
the patency assessment is therefore indeterminate. 
A repeat patency assessment should be made a few 
minutes later to see whether  ST resolution has 
indeed proceeded. When 50% recovery has 
occurred with the required downsloping peak 2- 
minute ST slope but is then followed by an upslop- 
ing ST trend, it is believed that this is due to recur- 
rent occlusion of the infarct-related artery, and this 
leads to assessment of the artery as occluded. 
If none o{ the recorded ECGs has an ST ampli- 
tude of 200 IJV or greater, a special statement is 
printed to the effect that the amplitudes are below 
the programmed threshold to perform a patency 
assessment. Thus, only if the current occlusion or a 
previous occlusion caused an ST amplitude of 200 
pV or greater in the selected lead will the algorithm 
perform a patency assessment. This min imum 
threshold was chosen because the accuracy of ST- 
segment recovery analysis may be reduced in 
patients with lower ST amplitudes during their 
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acute myocardial infarction (data from the GUSTO- 
1 ECG monitoring substudy). 
Endpoints 
For the purpose of this study, a patency assess- 
ment was performed on each ECG recorded every 
20 seconds before, during, and after each balloon 
inflation lasting at least 60 seconds. A balloon- 
induced occlusion was considered etected if the 
program produced at least one interpretative state- 
ment saying "occluded" during that inflation. For 
all detected balloon inflations, the following 
performance parameters were evaluated: (1) time 
from balloon inflation to the first assessment 
ECG with an interpretative statement saying 
"occluded"; (2) time from balloon deflation to the 
first assessment ECG with an interpretative state- 
ment no longer saying "occluded"; and (3) dura- 
tion of the episode during which interpretative 
statements aid "occluded" as compared with the 
actual duration of balloon inflation. 
Statistics 
All continuous variables are represented as 
median values, 25th-75th percentiles, and in rele- 
vant cases as ranges. Categorical parameters are 
represented as numbers of patients or number of 
inflations. Detection rates are reported as absolute 
numbers, percentages, and 95% confidence limits. 
Differences in detection rates over all inflations 
were tested by Fisher's exact test; P values < .05 
were considered significant. 
Results 
A total of 78 transient coronary occlusions were 
recorded from 31 coronary sites in 30 patients. The 
recordings of six patients were excluded from 
analysis: two underwent percutaneous translumi- 
hal coronary angioplasty of a totally occluded 
artery, two underwent angioplasty with a perfu- 
sion balloon catheter, one had continuous right 
bundle branch block, and one had incomplete left 
bundle branch block with axis changes during 
inflation. Table I summarizes ome of the charac- 
teristics of the stpdy population, The vessel dilated 
was the left anterior descending artery (LAD) in 10 
patients (26 inflations), the left circumflex artery 
(LCX) in l0 patients (22 inflations), and the right 
coronary artery (RCA) in l I patients (30 infla- 
tions). Median duration of inflation was 183 sec- 
onds (quartile range, 126-189 seconds; range, 
62-912 seconds). Median peak ST deviation per 
inflation was 165 pV (quartile range, 34-258 uV; 
range, - I90 -968 BV). Median peak ST deviation 
was 240 pV for LAD inflations (quartile range, 
115-303 pV; range, 65-968 uV); -20  I_IV for LCX 
inflations (quartile range, -95-15  IJV; range, 
-190-820 pV); and 205 uV for RCA inflations 
(quartile range, 78-275 pV; range, -20-395 uV). 
Median peak ST deviation was 175 IaV for first bal- 
loon inflations (quartile range, I5-235 uV; range, 
- 115 to 687 pV) and 160 uV for repeated balloon 
inflations (quartile range, 50-260 uV; range, 
-190-968 BV). Of the 78 inflations, there were 35 
(45%) causing peak ST amplitude at 200 DV or 
more, including 19 of 26 LAD inflations (73%), 1 
of 22 LCX inflations (5%), and 15 of 30 RCA infla- 
Table I. Patient Characteristics 
Sex 
M 15130 (50%) 
F 15130 (50%) 
Age (years) Median, 68 (quartile range, 51-75; range, 40-84) 
Hypertension 18130 (60%) 
Diabetes mellitus 12/30 (40%) 
Previous AMI same region 
Non-Q wave 5/30 (17%) 
Q wave 5/30 (17%) 
Indication 
Angina pectoris 15/30 (50%) 
Unstable angina 10/30 (33%) 
Post-AMI 4/30 (13%) 
Syncope 1/30 (3%) 
Extent of disease 
l vessel 14/30 (47%) 
2 vessels 8•30 (27%) 
3 vessels 8/30 (27%) 
Preangioplasty stenosis (%) Median, 95 (quartile range, 75-95; range, 75-99) 
AMI, acute myocardial infarction; post-AMI, >3 days after acute myocardial infarction. 
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tions (50%). All 35 inflations (100%) with 200 pV 
or greater peak ST amplitude were detected. Of the 
43 balloon inflations that caused less than 200 pV 
ST elevation, 5 were also detected (1 LAD, 1 LCX, 
3 RCA). In all five instances, the inflation followed 
a prior inflation that did cause a 200 BV or greater 
ST elevation, in which case the automated patency 
assessment program was allowed to produce a 
patency assessment s atement. 
In the 40 detected inflations, median time from 
balloon inflation to detection of occlusion was 40 
seconds (quartile range, 20-80 seconds; range, 
0- I20 seconds). Reperfusion by balloon deflation 
in those same 40 occlusions was detected at a 
median of 17 seconds (quartile range, -2 -16  sec- 
onds; range, -92-126 seconds). The median dura- 
tion of occlusion defined by the automated patency 
assessment program was 120 seconds of the actual 
median balloon inflation duration of 18i seconds 
in these 40 detected inflations. During six infla- 
tions, one or more ECGs were not analyzed owing 
to conduction changes (one, two, two, three, 
three, and four consecutive ECGs excluded, respec- 
tively) and one ECG during one inflation was not 
analyzed owing to the high noise content. 
After splitting the 78 balloon inflations around 
the median duration of inflation, no correlation 
was found between inflation duration and the pro- 
gram's detection performance (P = 1.0). Neither 
was there any difference in detection of first versus 
repeated balloon, inflations: 15 of 30 versus 25 of 
48, respectively (P = 1.0). 
The precordial location of the peak lead activity 
varied with the artery occluded. Of the standard 12 
leads monitored, the following peak leads were 
used to detect occlusions: leads V1 (2), V2 (8), V3 
(8), and V4 (2) for LAD occlusions; lead III (2) for 
LCX occlusions; and lead III (18) for RCA occlu- 
sions. Thus, detection of the occlusions occurred in 
five different leads. 
Discussion 
The results of this study show that this auto- 
mated patency assessment program wholly con- 
tained within the ST monitor's architecture 
detected all occlusions producing injury current of 
200 BV or greater, equivalent to entry criteria used 
in some thrombolytic trials. Detection of multiple 
episodes of occlusion and reperfusion was within 
seconds of their actual occurrence. Longer infla- 
tions did not increase the chance of detection in 
this model. This is probably due to our standard 
angioplasty practice of deflating the balloon earlier 
if ischemia induced by the occlusion is relatively 
severe, while dilating for longer periods if the 
patient olerates it well with no ischemia. In spon- 
taneous occlusion and infarction, longer acute 
occlusions would be expected to produce higher 
ST-segment amplitudes. Repeated inflations were 
detected as well as first inflations. Although one 
might expect lower amplitudes in repeated balloon 
inflations, this was not the case in this population. 
Furthermore, after an initial occlusion causing a 
200 pV or higher ST elevation, the program relies 
on ST trend slopes and amplitudes relative to the 
peak ST elevation rather than on absolute ampli- 
tudes. 
It is notable that the peak lead selected varied 
over the precordium with the artery occluded. This 
suggests that automated detection of coronary 
occlusion not only is a matter of updated assess- 
ments of ST amplitudes, but also is dependent on 
the ability to select a monitoring lead central to the 
geographic pattern of ST deviation 17-21). 
Limitations 
Elective coronary angioplasty is an imperfect 
model to test a program designed for acute myo- 
cardial infarction applications. It precludes an 
analysis of the sensitivity and specificity of auto- 
mated occlusion detection because detection of 
coronary occlusion while the balloon is deflated 
may signify other "true" occlusion causes, such as 
coronary occlusion by the guiding catheter or rapid 
thrombotic occlusion due to dissection of the arter- 
ial wall. Even injection of contrast solution into the 
coronary artery may result in temporary ST-seg- 
ment shifts. The fact that only 40 of the 78 balloon 
inflations produced enough injury current o fulfill 
the preset requirement of 200 pV illustrates 
another reason why coronary angioplasty is an 
imperfect model for coronary occlusion in acute 
myocardial infarction. On the basis of the entry cri- 
teria used for some thrombolytic trials, such ST 
levels are somewhat more common in the milieu 
of prolonged occlusion necrosis typical of actual 
acute myocardial infarction. In a standard 12-lead 
ECG format, such criteria have been demonstrated 
to promote an anatomic bias against LCX occlu- 
sions (17), which is unfortunately paralleled in 
these data taken during coronary angioplasty, with 
markedly lower peak ST elevation during occlu- 
sions of the LCX. In this regard, the percutaneous 
transluminal coronary angioplasty model emulated 
acute myocardial infarctions well, with most LCX 
balloon occlusions failing to produce the minimum 
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ST-segment elevation required by the automated 
patency program. 
Despite these limitations, coronary angioplasty 
provides a human model of coronary occlusion and 
reperfusion of known duration and location, which 
is very useful for prel iminary testing of a prototype 
patency assessment program. Every recorded ECG 
could thus be correlated with simultaneous angio- 
graphic documentat ion of the location and flow 
status of the artery. The previous work on which 
this program was modeled has demonstrated that 
during infarction the myocard ium generates and 
resolves ST-segrnent shift abruptly enough to make 
continuous ST recovery analysis a usefully accurate 
noninvasive marker  of patency (10-12). The 
results of this study suggest that further invest- 
igation into the performance of the automated 
patency assessment program during actual acute 
myocardial infarction is warranted. 
The time course of ST-segment change during 
acute myocardial infarction may be substantially 
different from trends obtained during coronary 
angioplasty and might be more heterogeneous. 
Whether  the anatomic bias or the overall perfor- 
mance of the program could be further optimized 
by changing minimal amplitude requirements or 
slope rates is beyond the scope of this balloon 
angioplasty model and needs further investigation 
in the acute myocardial infarction setting. Use of 
additional leads or modified lead systems might 
also enhance performance (20,21), especially to 
reduce the anatomic bias against LCX occlusions, 
although the 12-lead system is practical because of 
universal familiarity. The variety of leads used to 
detect coronary occlusion suggest that more 
restricted lead systems would risk decreasing the 
accuracy of the algorithm. They would also dimin- 
ish the ability to compare the precordial multi lead 
"fingerprint" patterns that are useful in discrimi- 
nating reocclusion of the culprit lesion from other 
sources of ST-segment deviation (17-20). Other 
modifications to reduce the anatomic bias and 
increase the program's ensitivity, such as variable 
thresholds, use of reciprocal ST depression, or 
coronary artery-specific algorithms may also bear 
exploration. 
Clinical Implications 
Within the controlled setting of coronary angio- 
plasty, the automated patency assessment program 
appears to be capable of noninvasive detection of 
coronary occlusion and reperfusion within seconds 
of their occurrence. Contained entirely within the 
architecture of a portable bedside ST monitor, this 
automated patency assessment program might 
become a practical and valuable tool in the man-  
agement of acute myocardial infarction patients 
following thrombolytic therapy. A large clinical 
field trial testing the program during actual acute 
myocardial infarction is currently ongoing. 
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